Richard A. Dart

APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy

Jeffrey B. Kopp, George W. Nelson, Karmini Sampath et al. · Journal of the American Society of Nephrology · 2011 · 859 citations · Full text

Medicine, Genetics, Nephrology +9

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

Jeffrey B. Kopp, Michael W. Smith, George W. Nelson et al. · Nature Genetics · 2008 · 708 citations

Medicine, Genetics, Molecular Genetics +13

The Long-Term Outcome of Patients with IgA Nephropathy Treated with Fish Oil in a Controlled Trial

James V. Donadío, Joseph P. Grande, Erik J. Bergstralh et al. · Journal of the American Society of Nephrology · 1999 · 204 citations

Medicine, Nephrology, Nutritional Sciences +17

Clinical Events in High-Risk Hypertensive Patients Randomly Assigned to Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

Frans H. H. Leenen, Chuke Nwachuku, Henry R. Black et al. · Hypertension · 2006 · 169 citations

Medicine, Cardiology, Pharmacotherapy +17

Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension

Henry R. Black, Barry R. Davis, Joshua I. Barzilay et al. · Diabetes Care · 2008 · 117 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16